Human Genome's Risk-Management Math
Executive Summary
Human Genome Sciences believes its lead in genomics--it claims to have nearly all human genes in its database--is already letting it beat the biotech odds in the clinic by allowing it to pick better proteins to develop and then follow them up with a virtually inexhaustible source of new candidates. Skeptics don't like the company's arithmetic.